Evidence map›Paper›PMID 32205370›Full record

ArticleBMJ open2020

Unmet needs and opportunities for improving care for patients with advanced lung cancer on targeted therapies: a qualitative study.

Morhaf Al Achkar, Lucille Marchand, Matthew Thompson, Laura Q M Chow, Debra Revere, Laura-Mae Baldwin

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Living WithJTO clinical and research reports · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. The Implementation of Decision Aids During Medical Consultations for Lung Cancer Patients: A Focus Group Within I3LUNG Project.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Comprehensive needs, social support, and disease perception in lung cancer patients treated with immune checkpoint inhibitors: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  12. Article
  13. Article
  14. A qualitative study of interactions with oncologists among patients with advanced lung cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  15. Article
  16. Observational
  17. Article
  18. Review
  19. Article
  20. A qualitative study of online support communities for lung cancer survivors on targeted therapies.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Morhaf Al AchkarFamily Medicine, University of Washington, Seattle, Washington, USA alachkar@uw.edu.ORCID 0000-0002-4160-0550
Lucille MarchandFamily Medicine, University of Washington, Seattle, Washington, USA.
Matthew ThompsonFamily Medicine, University of Washington, Seattle, Washington, USA.
Laura Q M ChowDepartment of Oncology, University of Texas at Austin, Dell Medical School, Austin, Texas, USA.
Debra RevereSchool of Public Health, University of Washington, Seattle, Washington, USA.
Laura-Mae BaldwinFamily Medicine, University of Washington, Seattle, Washington, USA.
University of Washington · USThe University of Texas at Austin · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveLung cancer is increasingly recognised as a heterogeneous disease. Recent advances with targeted therapies for lung cancer with oncogenic mutations have greatly improved the prognosis for this subset of patients, yet little is known about their experiences. This study aimed to identify the needs and explore the healthcare experiences of these advanced patients with oncogenic mutation driven lung cancer.

designQualitative interviews with patients with advanced or metastatic non-small cell lung cancer with oncogenic alterations in anaplastic lymphoma kinase, epidermal growth factor receptor or c-ros oncogene 1. SETTINGS: Patients were recruited from online lung cancer support groups within the USA. Interviews were conducted remotely or in person, transcribed verbatim and analysed using an iterative inductive and deductive process.

participantsWe included 39 patients (11 males and 28 females) with a median age of 48.

resultsTwo primary theme categories emerged: patients' unmet needs and improving healthcare experiences. Unmet needs are related to patients' desire to view their disease as a chronic illness, aspire to live a meaningful existence without financial devastation, desire for understanding along with emotional support and needing help with practical matters. Improving healthcare experiences involved patients' desire to trust the expertise of clinical providers, receive reliable care and be treated holistically and as informed partners.

conclusionsPatients with lung cancer with oncogenic mutations live uncharted experiences. Targeted therapy brings hope, but uncertainty is daunting. Patients grapple with the meaning and purpose of their lives while day-to-day obligations remain challenging. Healthcare teams are instrumental in their care experiences, and patients desire providers who are up-to-date on advances in the field and treat them as whole persons.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeeds AssessmentQuality of Health CareAgedFemaleHumansMaleMiddle AgedQualitative ResearchUnited StatesALKEGFRlung canceroncogenic alterationqualitative researchROS1

Identifiers

PMID32205370
PMCPMC7103815
OpenAlexW3012669721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.